Relay Therapeutics, Inc.
RLAY· Nasdaq
RLAYRelay Therapeutics, Inc.
Filed Feb 22, 2024 · 10-K · 53 days after period end · 0000950170-24-018797
derived · Computed from the longer spans the company filed.
| Metric | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures |
|---|---|---|---|---|
| Revenue | — | $253.00K | $567.00K | — |
| Net Income | -$83.50M | -$67.50M | -$67.46M | $35.28M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Relay Therapeutics, Inc. · CIK 1812364 · Engraved from SEC EDGAR
ended Dec 31, 2023 · filed Feb 22, 2024 · 53 d after period end
